Molecular determinants of sotorasib clinical efficacy inKRASG12C-mutated non-small-cell lung cancer This large integrated analysis of the KRASG12Cinhibitor sotorasib clinical efficacy biomarkers from the phase 2 CodeBreaK 100 and phase 3 CodeBreaK 200 trials shows that low expression of TTF-1 ...
All accepted abstracts will be published in respective Conference Series International Journals. Abstracts will be provided with Digital Object Identifier by Quick Links Abstracts Submission New RegistrationNew Scientific Program Organizing Committee Call for Abstracts ...
Research Highlight|22 March 2024 Biomarker shows no clinical use in guiding treatment for Crohn’s disease Eleni Kotsiliti World View|12 January 2024 Contrasting aspects of human excreta Our Ig Nobel Prize-winning smart toilet research confronts societal taboos and uses humour as a gateway to adva...
, 11., 12. but these must be placed in clinical context.13., 14. In view of recent developments in renal biomarker discovery, it is timely to review the cross-sectional and longitudinal observational studies investigating these in CKD. This review will first address biomarkers in CKD ...
点击API Access可见4种注册方式,可选择Research use in academic setting,然后使用edu邮箱注册,即可免费使用。 OncoKB数据库核心功能及操作演示 点击Cancer Genes可预览该数据库收录的全部肿瘤相关的基因突变信息: 第一列:基因名称 ①列打“√”的基因表示被OncoKB收录有注释信息,标“信封”的表示可点击信封标志申请添加...
Join 200+ senior executives in London as the leading meeting to explore the development of drug-diagnostics in diseases.
However, this federal law does not apply to life, long-term care, or disability insurers so it is legal to use genetic test results in these coverage or premium decisions. This panel brings together stakeholders from the patient, genetic counselor, lab, and research communities to explore: How...
Research Briefing | 22 November 2024 Using tumor DNA methylomes to predict cancer metastasis to the brain Metastatic spread of cancer to the brain has a devastating effect on patient outcomes, yet identifying patients who will develop brain metastases is difficult in current clinical practice. We...
Functional and structural brain asymmetries are a fundamental principle of brain organization, and research suggests substantial individual variability in these asymmetries that needs to be considered in clinical practice. This Review provides an overview of brain asymmetries, variations in such asymmetries ...
in predicting of response to therapies, adverse events and drug interactions, and in establishing baseline risk. The explosion of interest in biomarker research is driving the development of new predictive, diagnostic